Solventum SOLV United States — Total Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Solventum in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Solventum’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solventum's united states — total net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solventum's united states — total net sales?
- Solventum (SOLV) reported united states — total net sales of $1.17B in Q4 2025.
- How has Solventum's united states — total net sales changed year-over-year?
- Solventum's united states — total net sales increased by 2.4% year-over-year, from $1.14B to $1.17B.
- What is the long-term trend for Solventum's united states — total net sales?
- Over 3 years (2022 to 2025), Solventum's united states — total net sales has grown at a 1.6% compound annual growth rate (CAGR), from $4.45B to $4.67B.
- What does united states — total net sales mean?
- The total amount of money earned from customers located in the United States.
- How do you interpret united states — total net sales?
- An increase indicates growing market share or higher demand for products in the U.S., while a decrease may signal competitive pressure or market saturation.
- How does united states — total net sales compare across companies?
- Comparable to domestic revenue or regional net sales reported by other multinational healthcare and medical device companies.